Artificial Intelligence and its validated application in daily diabetes management I MELISSA project

The world’s first fully automated holistic AI-driven diabetes treatment personalisation and optimisation platform: MELISSA is developing a clinically validated, efficient and cost-effective Artificial Intelligence-based digital diabetes management solution for the benefit of people living with diabetes and healthcare professionals.
With the user-friendly and intelligent self-learning application introduced by the MELISSA project, people with diabetes who rely on the use of insulin will benefit from a personalised management system and can therefore enjoy a more carefree daily routine in living with diabetes.
Find out more on our website: www.melissa-di... and follow us on X: / melissadiabetes and LinkedIn: / melissadiabetes
_____________________________________________________________________________________________
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA).
Neither the European Union nor the granting authority can be held responsible for them. This work has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).